TG Therapeutics Inc (STU:NKB2)
€ 15.004 -0.278 (-1.82%) Market Cap: 2.33 Bil Enterprise Value: 2.24 Bil PE Ratio: 74.36 PB Ratio: 15.79 GF Score: 73/100

TG Therapeutics Inc ASH Abstract Release Conference Call Transcript

Nov 05, 2020 / 01:45PM GMT
Release Date Price: €24.35 (+2.74%)
Operator

Greetings, and welcome to TG Therapeutics Webinar ASH 2020 Abstract Release Call. (Operator Instructions). As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Michael Weiss, Chief Executive Officer of TG Therapeutics. Please proceed.

Michael S. Weiss
TG Therapeutics, Inc. - CEO & President

Great. Thank you, conference operator, and good morning, everybody, and thanks for joining us. So like a regular presentation, I guess, I'm going to do some forward-looking statements. Before I get started, I just want to remind everyone that I will be making some forward-looking statements. And for those who are interested in TG, I do encourage you to read our public disclosure documents available on the -- online.

Okay. So with that, let me start the call by just going through quickly the agenda for today. So first, I'm going to do a corporate update. The -- this will be in lieu of a quarterly conference call that we would normally host next week. So we're going to do some corporate housecleaning, do the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot